Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Med Phys. 2019 Jun 26;46(8):3356–3370. doi: 10.1002/mp.13641

Table VI.

OAR mean dose and max dose reduction of the SHBOO-FMO plans from the MAN-WC plans and MAN-SenR, for the SBT cases under nominal situation.

SBT Case SHBOO-FMO – MAN-WC (GyRBE) SHBOO-FMO – MAN-SenR (GyRBE)
Dmean Dmax Dmean Dmax
#1 #2 #1 #2 #1 #2 #1 #2
L Opt Nrv −5.06 −15.12 −1.40 −0.90 +0.07 −10.05 +0.83 +1.40
R Opt Nrv −13.93 −1.80 −4.57 −11.20 −2.07 −0.18 −2.00 −4.60
Chiasm −2.35 −13.72 −0.76 −7.18 −2.07 −5.14 +0.24 −4.18
Brainstem −1.45 −4.63 −5.75 −7.32 −0.37 −0.39 −3.33 +2.34
L Eye −0.57 −13.65 −5.42 −25.63 +0.50 −6.01 −2.23 −16.66
R Eye −1.21 0.00 −8.38 0.00 −0.13 0.00 −0.72 0.00
L Cochlea 0.00 −3.59 0.00 0.00 0.00 0.79 0.00 +1.20
R Cochlea 0.00 −4.89 0.00 −6.72 0.00 −2.06 0.00 −3.52